| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mai―30 |
Design and Evaluation of ATN-161 Analogues as Fusion Inhibitors Targeting Integrins in SARS-CoV-2 |
Marriam Munawar, Naeem-Ul-Haq Khan, Sobia Jabeen, Saman Taj, Rizwan Bashir, Wasim Abbas, et al. (+2) Waqar Rauf, Mazhar Iqbal |
| 2 |
[GO] |
2024―Nov―16 |
Utilization of Antiviral Peptides in Treating Coronavirus Infection: An Overview |
Qian Xu, Fangyu Wang, Hua Feng, Qiang Wei, Xuefeng Sun, Guangxu Xing, Gaiping Zhang |
| 3 |
[GO] |
2023―Aug―30 |
Molecular Modelling, Synthesis, and In-Vitro Assay to Identify Potential Antiviral Peptides Targeting the 3-Chymotrypsin-Like Protease of SARS-CoV-2 |
Ryan Faddis, Sydney Du, James Stewart, Mohammad Mehedi Hasan, Noam Lewit, Md Ackas Ali, et al. (+4) Cladie B. White, Patience Okoto, Sures Thallapuranam, Mohammad A. Halim |
| 4 |
[GO] |
2023―Jul―17 |
Designing a Novel Spike Linear B-Cell Epitopes (SLBE) Protein with High Performance in Sars-Cov2-ELISA Test |
Majid Esmaelizad, Maedeh Hamidizadeh, Nazanin Esmaelizad, Mohammad Doroudian, Mohammad Ranjbar, Mohsen Lotfi |
| 5 |
[GO] |
2023―Mai―30 |
Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients |
Motahareh Zeinivand, Masoomeh Sharifi, Gholamhossein Hassanshahi, Seyed Ershad Nedaei |
| 6 |
[GO] |
2022―Aug―22 |
SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective |
Abdo A. Elfiky, Ibrahim M. Ibrahim, Alaa M. Elgohary |
| 7 |
[GO] |
2022―Apr―19 |
Peptide-Based Vaccines and Therapeutics for COVID-19 |
Pritam V. Bagwe, Priyal V. Bagwe, Sai Srinivas Ponugoti, Shreerang V. Joshi |
| 8 |
[GO] |
2022―Mrz―16 |
Immunogenic Epitope-Based Vaccine Prediction from Surface Glycoprotein of MERS-CoV by Deploying Immunoinformatics Approach |
Truc Ly Nguyen, Youngho Lee, Heebal Kim |
| 9 |
[GO] |
2022―Jan―24 |
Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19 |
Aparajita Sen, Arti Nigam, Meenakshi Vachher |
| 10 |
[GO] |
2022―Jan―21 |
Exploring Structural Mechanism of COVID-19 Treatment with Glutathione as a Potential Peptide Inhibitor to the Main Protease: Molecular Dynamics Simulation and MM/PBSA Free Energy Calculations Study |
Abderahmane Linani, Khedidja Benarous, Leila Bou-Salah, Mohamed Yousfi, Souraya Goumri-Said |
| 11 |
[GO] |
2022―Jan―03 |
Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus |
Yasaman Behzadipour, Shiva Hemmati |
| 12 |
[GO] |
2022―Jan―03 |
In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein |
Gunderao H. Kathwate |
| 13 |
[GO] |
2021―Dez―13 |
In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern |
Sajjan Rajpoot, Kundan Solanki, Ashutosh Kumar, Kam Y. J. Zhang, Soni Savai Pullamsetti, Rajkumar Savai, et al. (+3) Syed M. Faisal, Qiuwei Pan, Mirza S. Baig |
| 14 |
[GO] |
2021―Dez―09 |
In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides |
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi, Reza Mirnejad |
| 15 |
[GO] |
2021―Jul―10 |
Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research |
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee |
| 16 |
[GO] |
2021―Jul―10 |
New Computational Approach for Peptide Vaccine Design Against SARS-COV-2 |
Subhamoy Biswas, Smarajit Manna, Ashesh Nandy, Subhash C. Basak |
| 17 |
[GO] |
2021―Apr―16 |
Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics |
Richa Jain, Ankit Jain, Santosh kumar Verma |
| 18 |
[GO] |
2021―Apr―16 |
Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection |
Abbas Jafari, Sonia Sadeghpour, Hojat Ghasemnejad-Berenji, Sarvin Pashapour, Morteza Ghasemnejad-Berenji |
| 19 |
[GO] |
2021―Apr―08 |
Identification of Potential Peptide Inhibitors of ACE-2 Target of SARS-CoV-2 from Buckwheat & Quinoa |
Ashok Nanjaiah Rangaswamy, Arpitha Ashok, Pradeep Hanumanthappa, Aparanji Sinduvalli Chandrashekaramurthy, Monika Kumbaiah, Pratibha Hiregouda, et al. (+2) Vaishali Sharma, Aparna Huligerepura Sosalegowda |
| 20 |
[GO] |
2021―Mrz―17 |
In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2 |
M A. Siddiqa, D. S. Rao, G. Suvarna, V. K. Chennamachetty, M. K. Verma, M. V. R. Rao |
| 21 |
[GO] |
2020―Nov―10 |
Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach |
Janish Kumar, Rahila Qureshi, Someswar R. Sagurthi, Insaf Ahmed Qureshi |
| 22 |
[GO] |
2020―Sep―28 |
Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease |
Vijayakumar Balakrishnan, Karthik Lakshminarayanan |
